HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.

Abstract
In view of the pivotal role of glutamate carboxypeptidase II (GCPII) in carcinogenesis, its expression as prostate specific membrane antigen (PSMA) and folate hydrolase (FOLH1) may be influenced by its haplotypes, contributing to the etiology of prostate and breast cancer. To test this hypothesis, breast and prostate cancer cases and controls were subjected to whole gene screening of GCPII and correlated with plasma folate levels and PSMA expression. The impact of variants on a 3-dimensional structure of GCPII was explored by in silico studies. Six novel variations i.e. V108A, P160S, Y176H, D191V, G206R and G245S; and two known variations i.e. R190W and H475Y were identified in GCPII. All-wild haplotype and a haplotype harbouring D191V showed association with breast cancer risk while haplotypes harbouring V108A and P160S reduced the risk. Haplotypes with V108A and G245S variants showed increased risk for prostate cancer due to high PSMA expression while P160S conferred protection against prostate cancer. In silico studies suggests that P160S and R190W variants result in relaxed substrate binding facilitating either rapid catalysis or exchange of substrates and products in the active site which was substantiated by high plasma folate levels associated with these variants. On the contrary, D191V was associated with very low plasma folate levels despite having a high PSMA expression. This is the first comprehensive study examining variations in GCPII in relation to breast and prostate cancer risk. Changes in the plasma folate levels and changes in PSMA expression are associated with breast and prostate cancer risk respectively.
AuthorsShree Divyya, Shaik Mohammad Naushad, Anthony Addlagatta, P V L N Murthy, Ch Ram Reddy, Raghunadha Rao Digumarti, Suryanarayana Raju Gottumukkala, Sreedhar Amere Subbarao, Vijay Kumar Kutala
JournalGene (Gene) Vol. 516 Issue 1 Pg. 76-81 (Mar 01 2013) ISSN: 1879-0038 [Electronic] Netherlands
PMID23266799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, Surface
  • Folic Acid
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II
Topics
  • Adult
  • Aged
  • Antigens, Surface (genetics)
  • Breast Neoplasms (genetics)
  • Case-Control Studies
  • Female
  • Folic Acid (administration & dosage, blood)
  • Gene Expression Regulation, Neoplastic
  • Glutamate Carboxypeptidase II (genetics)
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Prostatic Neoplasms (genetics)
  • Protein Conformation
  • Risk Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: